Your browser doesn't support javascript.
Coronavirus disease 2019 in an orthotopic liver transplant recipient living with human immunodeficiency virus.
Modi, Anita R; Koval, Christine E; Taege, Alan J; Modaresi Esfeh, Jamak; Eghtesad, Bijan; Narayanan Menon, K V; Quintini, Cristiano; Miller, Charles.
  • Modi AR; Department of Infectious Disease, Respiratory Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.
  • Koval CE; Department of Infectious Disease, Respiratory Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.
  • Taege AJ; Department of Infectious Disease, Respiratory Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.
  • Modaresi Esfeh J; Department of Gastroenterology and Hepatology, Digestive Disease and Surgery Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.
  • Eghtesad B; Department of General Surgery, Digestive Disease and Surgery Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.
  • Narayanan Menon KV; Department of Gastroenterology and Hepatology, Digestive Disease and Surgery Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.
  • Quintini C; Department of General Surgery, Digestive Disease and Surgery Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.
  • Miller C; Department of General Surgery, Digestive Disease and Surgery Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.
Transpl Infect Dis ; 22(5): e13351, 2020 Oct.
Article in English | MEDLINE | ID: covidwho-539680
ABSTRACT
Coronavirus disease 2019 (COVID-19), mediated by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), can manifest with flu-like illness and severe pneumonia with acute respiratory distress syndrome (ARDS). Immunocompromised patients merit particular attention as altered host immunity may influence both disease severity and duration of viral shedding as is described with several other ribonucleic acid respiratory viruses. Yet immunocompromised status alone, in the absence of other comorbidities, may not necessarily predict severe illness presentations and poorer clinical outcomes as indicated by recent reports of COVID-19-infected solid organ transplant recipients and people living with human immunodeficiency virus (HIV). Such patients may even be spared the robust inflammatory response that precipitates ARDS associated with COVID-19, complicating the management of iatrogenic immunosuppression in this setting. We present a case of an orthotopic liver transplant recipient with well-controlled HIV who successfully recovered from a mild, flu-like illness attributed to SARS-CoV-2.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: HIV Infections / Liver Transplantation / Anti-HIV Agents / SARS-CoV-2 / COVID-19 Type of study: Case report / Diagnostic study / Experimental Studies / Observational study / Prognostic study Limits: Adult / Humans / Male Language: English Journal: Transpl Infect Dis Journal subject: Transplantation Year: 2020 Document Type: Article Affiliation country: Tid.13351

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: HIV Infections / Liver Transplantation / Anti-HIV Agents / SARS-CoV-2 / COVID-19 Type of study: Case report / Diagnostic study / Experimental Studies / Observational study / Prognostic study Limits: Adult / Humans / Male Language: English Journal: Transpl Infect Dis Journal subject: Transplantation Year: 2020 Document Type: Article Affiliation country: Tid.13351